News

VILVI Group Reports Strong Revenue Growth in Early 2025

VILVI Group Reports Strong Revenue Growth in Early 2025

VILVI Group's Impressive Financial Performance

VILVI Group has announced its preliminary unaudited financial results for the first three months of 2025, showcasing remarkable performance. The consolidated sales revenue for this period reached an impressive EUR 71.1 million, reflecting a significant increase of 26.5% compared to the same period in the previous year, where the revenue amounted to EUR 56.2 million.

Net Profit Analysis

Despite the growth in sales, the Group reported a consolidated net profit of EUR 4.0 million for the first quarter of 2025. This figure signifies a 17.8% decline when juxtaposed with the net profit of EUR 4.9 million achieved in Q1 2024. It is essential to delve deeper into the factors influencing this profit decrease, which could be associated with various operational costs or market conditions.

About VILVI Group

The VILVI Group, a notable player in the dairy industry, encompasses an array of companies including Vilkyški? pienin?, Modest, Kelm?s pienin?, Kelm?s pienas, Pieno logistika located in Lithuania, and the Baltic Dairy Board situated in Latvia. The collective efforts of these entities have propelled the Group to achieve consolidated sales revenues of EUR 245.4 million in 2024. Furthermore, the net profit for the previous year stood at EUR 25.7 million, and with EBITDA hitting EUR 33.6 million, these numbers highlight the Group's stability and growth trajectory.

Future Outlook for VILVI Group

Looking ahead, VILVI Group aims to continue its trajectory of growth while navigating the challenges that come with fluctuations in market dynamics. Their commitment to quality and innovation in the dairy sector positions them favorably for future opportunities. Stakeholders will be keen to witness how the Group adapts to ensure sustained profitability amidst the inevitable fluctuations in the business environment.

Leadership Contact Information

For those interested in more detailed information about VILVI Group’s operations and financial progress, please reach out to:

Vilija Milaseviciute
Economics and Finance Director
Phone: +370 441 55 102
Email: vilija.milaseviciute@vilvi.eu

Frequently Asked Questions

What was the revenue for VILVI Group in the first quarter of 2025?

The consolidated revenue for the first three months of 2025 was EUR 71.1 million.

How does the first quarter profit of 2025 compare to last year?

The consolidated net profit for Q1 2025 was EUR 4.0 million, which is a decrease of 17.8% from EUR 4.9 million in Q1 2024.

Which companies are included in the VILVI Group?

The VILVI Group comprises Vilkyški? pienin?, Modest, Kelm?s pienin?, Kelm?s pienas, Pieno logistika, and Baltic Dairy Board.

What was the total revenue of VILVI Group for 2024?

VILVI Group recorded a total revenue of EUR 245.4 million for the year 2024.

Which ticker symbol represents VILVI Group?

The VILVI Group is represented by the ticker Vilnius:VLP1L.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading